CHAMPIONS ONCOLOGY, INC.

For the period ended Apr 30, 2025. Filed Jul 23, 2025.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Jul 23, 2025

CSBR$4.84+1.0%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Balance Sheets

AS OF APRIL 30

(In Thousands except for shares)

	2025	2024
ASSETS
Current assets:
Cash	$9,785	$2,618
Accounts receivable, net	11,234	9,526
Prepaid expenses and other current assets	1,350	1,495
Total current assets	22,369	13,639
Operating lease right-of-use assets, net	5,080	6,252
Property and equipment, net	4,375	5,721
Other long term assets	185	185
Goodwill	335	335
Total assets	$32,344	$26,132
LIABILITIESAND STOCKHOLDERS' EQUITY (DEFICIENCY)
Current liabilities:
Accounts payable	$4,248	$5,800
Accrued liabilities	2,556	2,160
Current portion of operating lease liabilities	1,471	1,337
Other current liabilities	135	150
Deferred revenue	15,443	12,094
Total current liabilities	23,853	21,541
Non-current portion operating lease liabilities	4,634	6,093
Other non-current liabilities	85	401
Total liabilities	$28,572	$28,035
Stockholders' equity (deficiency):
Common stock, $.001 par value; 200,000,000 shares authorized; 13,897,503 and 13,714,099 shares issued; and 13,777,170 and 13,593,766 shares outstanding at April 30, 2025 and 2024, respectively	14	14
Treasury Stock, at cost	(708)	(708)
Additional paid-in capital	84,358	83,384
Accumulated deficit	(79,892)	(84,593)
Total stockholders' equity (deficiency)	3,772	(1,903)
Total liabilities and stockholders' equity (deficiency)	$32,344	26,132

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.